Skip to main content
TipRanks
Go Ultimate75% OFF

Nanjing Leads Biolabs Co., Ltd. Class H (9887) Financial Statements

4 Followers

Nanjing Leads Biolabs Co., Ltd. Class H Financial Overview

Nanjing Leads Biolabs Co., Ltd. Class H's market cap is currently ¥6.40B. The company's EPS TTM is ¥-1.39; its P/E ratio is -19.77; Nanjing Leads Biolabs Co., Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue¥ 197.20M¥ 0.00¥ 9.75M¥ 0.00
Gross Profit¥ 197.20M¥ 0.00¥ 6.25M¥ -17.78M
Operating Income¥ -216.42M¥ -39.84M¥ -289.65M¥ -213.54M
EBITDA¥ -195.21M¥ -13.80M¥ -265.74M¥ -195.76M
Net Income¥ -235.21M¥ -43.90M¥ -398.61M¥ -286.77M
Balance Sheet
Cash & Short-Term Investments¥ 1.55B¥ 538.72M¥ 347.65M¥ 486.56M
Total Assets¥ 1.78B¥ 669.44M¥ 447.48M¥ 615.39M
Total Debt¥ 280.56M¥ 266.48M¥ 67.09M¥ 1.19B
Net Debt¥ -940.59M¥ -106.07M¥ -180.44M¥ 936.72M
Total Liabilities¥ 515.61M¥ 403.88M¥ 1.40B¥ 1.21B
Stockholders' Equity¥ 1.27B¥ 265.56M¥ -948.80M¥ -597.95M
Cash Flow
Free Cash Flow¥ -164.84M¥ -121.79M¥ -204.41M¥ -74.37M
Operating Cash Flow¥ -154.43M¥ -118.82M¥ -192.69M¥ -44.62M
Investing Cash Flow¥ -165.13M¥ -67.30M¥ 135.49M¥ 55.24M
Financing Cash Flow¥ 1.19B¥ 309.02M¥ 49.49M¥ -3.18M

Currency in CNY

Nanjing Leads Biolabs Co., Ltd. Class H Earnings and Revenue History

-500M-250M0250M-4500 %-3000 %-1500 %0 %EarningsProfit Margin2022202320242025RevenueEarningsProfit Margin

Nanjing Leads Biolabs Co., Ltd. Class H Liabilities to Assets

0800M1.6B2.4B0 %120 %240 %360 %LiabilitiesLiabilities to Assets2022202320242025AssetsLiabilitiesLiabilities to Assets

Nanjing Leads Biolabs Co., Ltd. Class H Cash Flow

-500M-250M0250M500M750M1B1.3B1.5B2022202320242025OperatingInvestingFinancing

Nanjing Leads Biolabs Co., Ltd. Class H Forecast EPS vs Actual EPS

-1.5-1.2-1-0.7-0.5-0.20Q2 25Q4 25Q2 26EPS EstimateBeatMiss